In the Fred Hutch Innovation Lab, we are leading the in-house development and early adoption of powerful new research technologies that hold the potential to drive lifesaving discoveries in cancer immunology and other areas of science.
Our lab is one of the hallmarks of Fred Hutch’s Steam Plant building, a historic landmark newly redeveloped into a one-of-a-kind facility dedicated to spurring innovation at the nexus of data science and immunology.
There, we use a three-stage pipeline to develop novel technologies for use by the scientific community. First, we test, compare, advance and tailor new technologies that our Advisory Board has selected for their potential to facilitate the next discoveries in immunotherapy. Then, we work with selected researchers to evaluate the technology as they harness it to advance their early-stage research projects. Finally, we make that technology and the protocols and procedures we’ve developed available to researchers across the Hutch to accelerate their science.
Dr. Adair is developing gene therapies that safely fine-tune the DNA sequences of blood stem cells to treat genetic disorders, HIV and cancers. Her goal is to develop safe, cost-effective and clinically relevant applications for gene therapy that can be implemented worldwide.
Dr. Dorer is the Vice President of Fred Hutch’s Interdisciplinary Science Administration (ISA). ISA includes key strategic investments that support science broadly across Fred Hutch including Integrated Research Centers, clinical research operations and Shared Resources
Dr. Gottardo is a computational biologist who specializes in the application of rapidly evolving ideas in data science to solve problems in cancer and related diseases. He is scientific director of Fred Hutch’s Translational Data Science Integrated Research Center.